<p>GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin

Published:2020-06 Issue: Volume:Volume 13 Page:6303-6314
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Nie Yanting,Ding Yiling,Yang Mengyuan

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference36 articles.

1. Ovarian cancer

2. Ovarian cancer statistics, 2018

3. Cancer statistics, 2019

4. Corrections to “Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

5. PARP inhibition in platinum-based chemotherapy: Chemopotentiation and neuroprotection

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Transcriptional Reprogramming of Mesenchymal Glioblastoma with Grainyhead-like 2 and HDAC Inhibitors Leads to Apoptosis and Cell-Cycle Dysregulation;Genes;2023-09-12

2. Telomere-related genes as potential biomarkers to predict endometriosis and immune response: Development of a machine learning-based risk model;Frontiers in Medicine;2023-03-09

3. GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression;Molecular and Cellular Biology;2022-10-01

4. Targeting grainyhead-like transcription factor 2/Snail2 with chitosan-lipid nanoparticles inhibits melanoma progression;Materials Express;2021-07-01

5. LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305;OncoTargets and Therapy;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3